Opening Up the Findings of Drug Trials
Although there is wide agreement that the system for reporting on clinical trials needs an overhaul, there are sharp disagreements on just how to do it. And the issue is in danger of getting short shrift as a Sept. 30 deadline approaches for broader House and Senate legislation to revamp the whole drug safety system.
Clinical trials, in which patients use a new drug and are watched closely for signs of trouble, are considered the gold standard to ...
Full Story »
